Scarica l'app Stockscreener
0.00
100.00%
-9.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALVR Giù?
Forum
Previsione
Allovir Inc Borsa (ALVR) Ultime notizie
Deadline to Claim Your Payout from the AlloVir Settlement Is in 1 Month - TradingView
AlloVir Is Paying a Settlement to Investors — Here’s How to Get Your Share - TradingView
ALVR SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating AlloVir Inc. (ALVR) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating AlloVir Inc. (ALVR) And Encourages Investors to Connect - ACCESS Newswire
Allovir (NASDAQ:KLRS) Rating Increased to Hold at Wall Street Zen - Defense World
Deadline to Claim Your Payout from the AlloVir Settlement Is in 2 Months - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages AlloVir Inc. (ALVR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
AlloVir, Inc. (NASDAQ:ALVR) Stake Lowered by Two Sigma Investments LP - Defense World
AlloVir Inc. (ALVR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Caribou Biosciences (NASDAQ:CRBU) versus AlloVir (NASDAQ:ALVR) Critical Contrast - Defense World
Squarepoint Ops LLC Invests $142,000 in AlloVir, Inc. (NASDAQ:ALVR) - Defense World
Allovir (NASDAQ:KLRS) Cut to Sell at Wall Street Zen - Defense World
Jane Street Group LLC Buys 39,808 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AlloVir Inc. (ALVR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Two Sigma Advisers LP Sells 11,800 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating AlloVir Inc. (ALVR) And Encourages Stockholders to Connect - ACCESS Newswire
Bernstein Liebhard LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of AlloVir, Inc. Securities - TradingView
Millennium Management LLC Sells 251,018 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World
Wall Street Zen Upgrades Allovir (NASDAQ:KLRS) to Hold - MarketBeat
BNP Paribas Financial Markets Acquires New Holdings in AlloVir, Inc. (NASDAQ:ALVR) - Defense World
AlloVir Inc. (ALVR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AlloVir Inc. (ALVR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Allovir (NASDAQ:KLRS) Upgraded to “Hold” at Wall Street Zen - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages AlloVir Inc. (ALVR) Investors to Inquire about Securities Investigation - ACCESS Newswire
Kalaris: Phase 1 Trial for TH103 Advances Following AlloVir Merger and Other Important Updates - TradingView
Allovir (NASDAQ:KLRS) Rating Lowered to Sell at Wall Street Zen - Defense World
Deadline to Claim Your Payout from the AlloVir $ALVR Settlement Is in 3 Months - TradingView
AlloVir ($ALVR) Is Paying a Settlement to Investors — Here’s How to Get Your Share - TradingView
Kalaris Therapeutics, Inc. SEC 10-Q Report - TradingView
Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights - The Manila Times
Kalaris Eyes Breakthrough in AMD Treatment: Phase 1 Trial Progress and $101M War Chest Revealed in Q1 Earnings - Stock Titan
EX-99.3 - SEC.gov
Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir LawsuitALVR - ACCESS Newswire
AlloVir, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your RightsALVR - ACCESS Newswire
Lost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class ActionALVR - ACCESS Newswire
Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineALVR - ACCESS Newswire
Renaissance Technologies LLC Trims Stock Position in AlloVir, Inc. (NASDAQ:ALVR) - Defense World
DEADLINE ALERT: Bernstein Liebhard LLP Reminds AlloVir, Inc. Investors of Upcoming Deadline - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineALVR - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Levi & Korsinsky Notifies AlloVir, Inc.(ALVR) Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com
Halper Sadeh LLP, AlloVir, Inc., Avid Bioservices, Inc., EMCORE Corporation - The Bradford Era
Halper Sadeh LLP, Aerovate Therapeutics, Inc., Staffing 360 Solutions, Inc., Allovir - The Bradford Era
AlloVir Announces FDA Clearance of Investigational New Drug Application for ALVR106, an Allogeneic, Off-The-Shelf, Multi-Virus Specific T Cell Therapy Targeting Four Devastating Respiratory Viruses - marketscreener.com
William Blair Initiates Kalaris Therapeutics With Outperform Rating - MarketScreener
(ALVR) Technical Data - news.stocktradersdaily.com
Kalaris Therapeutics appoints new board chair By Investing.com - Investing.com Canada
The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024(NASDAQ: ALVR) - MarketScreener
0.87%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):